CrossrefInfokarte
Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy
encephalitis · 2021
DOI: 10.47936/encephalitis.2021.00038 ↗Abstract
Kein Abstract verfügbar.
EUVIMED